ArticlePloS one2011

Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.

Jiahui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.